MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
MDGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Madrigal Pharmaceuticals (MDGL) Earnings Date & Reports

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality... Show more

A.I. Advisor
published Earnings

MDGL is expected to report earnings to rise 76.32% to -334 cents per share on October 30

Madrigal Pharmaceuticals MDGL Stock Earnings Reports
Q3'25
Est.
$-3.35
Q2'25
Beat
by $1.73
Q1'25
Beat
by $0.54
Q4'24
Beat
by $1.77
Q3'24
Beat
by $1.84
The last earnings report on August 05 showed earnings per share of -189 cents, beating the estimate of -363 cents. With 31.85K shares outstanding, the current market capitalization sits at 7.71B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Earnings TradersEarnings Traders
Annualized Return+23%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
MDGL
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For MDGL
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MDGL showed earnings on August 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a developer of small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
200 Barr Harbor Drive
Phone
+1 267 824-2827
Employees
276
Web
http://www.madrigalpharma.com